Chemours Company
CC
Market Cap$3.94B
Close$
$25.40
3.9% downside
Current Fair Value
3.9% downsideOvervalued by 3.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.94 Billion |
|---|---|
| Enterprise Value | $6.78 Billion |
| Dividend Yield | $0.987 (3.73%) |
| Earnings per Share | $-1.6 |
| Beta | 1.64 |
| Outstanding Shares | 148,880,950 |
| Avg 30 Day Volume | 1,644,090 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -16.56 |
|---|---|
| PEG | 22.95 |
| Price to Sales | 0.66 |
| Price to Book Ratio | 6.61 |
| Enterprise Value to Revenue | 1.12 |
| Enterprise Value to EBIT | -144.2 |
| Enterprise Value to Net Income | -29 |
| Total Debt to Enterprise | 0.6 |
| Debt to Equity | 5.48 |
Revenue Sources
No data
ESG Score
No data
About Chemours Company
7,000 employees
CEO: Mark Vergnano The Chemours Company is a global leader in Titanium Technologies, Fluoroproducts, and Chemical Solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemi...